| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |